Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk FactorsNorimichi Chiyonobu, Shinji Tanaka, Hiroaki Ono et al.|American Journal Of Pathology|2018Cited by 83
Dipeptidyl peptidase-4 inhibition prevents nonalcoholic steatohepatitis–associated liver fibrosis and tumor development in mice independently of its anti-diabetic effectsMitsuhiro Kawakubo, Takayoshi Suganami, Miyako Tanaka et al.|Scientific Reports|2020Cited by 72
The sodium-glucose cotransporter-2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis–associated liver tumors in a novel murine modelNaoki Yoshioka, Takayoshi Suganami, Miyako Tanaka et al.|Biomedicine & Pharmacotherapy|2021Cited by 29
Loss of KDM6B epigenetically confers resistance to lipotoxicity in nonalcoholic fatty liver disease–related HCCMegumi Hatano, Shinji Tanaka, Yoshimitsu Akiyama et al.|Hepatology Communications|2023Cited by 12